We recently compiled a list of the Top 10 AI Stocks on Wall Street’s Radar Right Now. In this article, we are going to take a ...

Barry Bannister, Stifel chief equity strategist, joins CNBC's 'Squawk on the Street' to discuss market outlooks for 2025.

Stifel upgraded Old Dominion (ODFL) to Buy from Hold with a price target of $200, up from $193. With the less-than-truckload group de-rating on ...

Stifel initiated coverage of Beta Bionics (BBNX) with a Buy rating and $25 price target The insulin-dependent diabetes opportunity is “large ...

Truist Financial Corp trimmed its position in shares of Stifel Financial Corp. (NYSE:SF – Free Report) by 39.4% during the ...

Inflation probably isn't going back to 2% without a recession, according to Barry Bannister, Stifel's top stock strategist.

Research analysts at Stifel Canada lowered their FY2024 earnings estimates for Mattr in a report released on Thursday, ...

Ahead of the company's report on Monday before the market open, shares are up more than 12% year to date, compared to the S&P ...

Fintel reports that on February 21, 2025, Stifel downgraded their outlook for Cheniere Energy Partners, L.P. - Limited ...

Neurogene Inc. (NASDAQ: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neu ...

As the flurry of executive orders continues to flow from the White House, leaving in its wake chaos and confusion across the ...

With Trevi poised to soon announce data from a trial of its Haduvio drug as a treatment for refractory chronic cough (RCC), ...